Guanxinning Tablet Alleviates Post-Ischemic Stroke Injury Via Regulating Complement and Coagulation Cascades Pathway and Inflammatory Network Mobilization DOI Creative Commons
Yule Wang, Yiran Li, Yue Zhou

и другие.

Drug Design Development and Therapy, Год журнала: 2024, Номер Volume 18, С. 4183 - 4202

Опубликована: Сен. 1, 2024

Currently, ischemic stroke (IS) continues to significantly contribute functional deterioration and reduced life quality. Regrettably, the choice of neuro-rehabilitation interventions enhance post-IS outcomes is limited. Guanxinning tablet (GXNT), a multi-component medicine composed Danshen Chuanxiong, has demonstrated neuroprotective potential against brain injury diabetic encephalopathy. However, therapeutic impact GXNT on pathological injury, as well underlying molecular mechanisms anti-IS active substances, remain unclear.

Язык: Английский

Network pharmacology, molecular docking, and in vitro experimental verification of the mechanism of Guanxining in treating diabetic atherosclerosis DOI
Wenting Wang, Sutong Wang, Yiwen Li

и другие.

Journal of Ethnopharmacology, Год журнала: 2024, Номер 324, С. 117792 - 117792

Опубликована: Янв. 28, 2024

Язык: Английский

Процитировано

2
“NO” controversy?: A controversial role in insulin signaling of diabetic encephalopathy DOI
Xi Chen, Ying Song, Hong Ye

и другие.

Molecular and Cellular Endocrinology, Год журнала: 2024, Номер 593, С. 112346 - 112346

Опубликована: Авг. 14, 2024

Язык: Английский

Процитировано

0
Guanxinning Tablet Alleviates Post-Ischemic Stroke Injury Via Regulating Complement and Coagulation Cascades Pathway and Inflammatory Network Mobilization DOI Creative Commons
Yule Wang, Yiran Li, Yue Zhou

и другие.

Drug Design Development and Therapy, Год журнала: 2024, Номер Volume 18, С. 4183 - 4202

Опубликована: Сен. 1, 2024

Currently, ischemic stroke (IS) continues to significantly contribute functional deterioration and reduced life quality. Regrettably, the choice of neuro-rehabilitation interventions enhance post-IS outcomes is limited. Guanxinning tablet (GXNT), a multi-component medicine composed Danshen Chuanxiong, has demonstrated neuroprotective potential against brain injury diabetic encephalopathy. However, therapeutic impact GXNT on pathological injury, as well underlying molecular mechanisms anti-IS active substances, remain unclear.

Язык: Английский

Процитировано

0